Reporting of results in ClinicalTrials.gov and high-impact journals

JAMA

Volumn 311, Issue 10, 2014, Pages 1063-1065

  Becker, Jessica E ^a   Krumholz, Harlan M ^a   Ben Josef, Gal ^a   Ross, Joseph S ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACCURACY; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL TRIAL (TOPIC); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; HUMAN; HYPERLIPIDEMIA; INFECTION; INFORMATION PROCESSING; MEDICAL LITERATURE; MEDICAL RESEARCH; NEOPLASM; PRIORITY JOURNAL; PUBLICATION;

CLINICAL TRIALS AS TOPIC; CROSS-SECTIONAL STUDIES; DATABASES, FACTUAL; ENDPOINT DETERMINATION; JOURNAL IMPACT FACTOR; MANDATORY PROGRAMS; PEER REVIEW, RESEARCH; PUBLISHING; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN; TREATMENT OUTCOME;

EID: 84896759357     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2013.285634     Document Type: Article

References (5)

1. Ross JS, Mulvey GK, Hines EM, Nissen SE, Krumholz HM. Trial publication after registration in ClinicalTrials.gov: a cross-sectional analysis. PLoS Med. 2009;6(9):e1000144.
2. Zarin DA, Tse T, Ide NC. Trial registration at ClinicalTrials.gov between May and October 2005. N Engl J Med. 2005;353(26):2779-2787.
3. Mathieu S, Boutron I, Moher D, Altman DG, Ravaud P. Comparison of registered and published primary outcomes in randomized controlled trials. JAMA. 2009;302(9):977-984.
4. Zarin DA, Tse T, Williams RJ, Califf RM, Ide NC. The ClinicalTrials.gov results database: update and key issues. N Engl J Med. 2011;364(9):852-860.
5. Turner EH, Matthews AM, Linardatos E, Tell RA, Rosenthal R. Selective publication of antidepressant trials and its influence on apparent efficacy. N Engl J Med. 2008;358(3):252-260.